These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32157381)

  • 1. Infection severity across scales in multi-strain immuno-epidemiological Dengue model structured by host antibody level.
    Gulbudak H; Browne CJ
    J Math Biol; 2020 May; 80(6):1803-1843. PubMed ID: 32157381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection, Altered Vector Infectivity, and Antibody-Dependent Enhancement: The Dengue-Zika Interplay.
    Olawoyin O; Kribs C
    Bull Math Biol; 2020 Jan; 82(1):13. PubMed ID: 31933003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants.
    Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP
    Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of an asymmetric two-strain dengue model.
    Kooi BW; Aguiar M; Stollenwerk N
    Math Biosci; 2014 Feb; 248():128-39. PubMed ID: 24434818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Optimal Age of Vaccination Against Dengue with an Age-Dependent Biting Rate with Application to Brazil.
    Maier SB; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Bull Math Biol; 2020 Jan; 82(1):12. PubMed ID: 31933012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the Host Immune Response to Mature and Immature Dengue Viruses.
    Borisov M; Dimitriu G; Rashkov P
    Bull Math Biol; 2019 Dec; 81(12):4951-4976. PubMed ID: 31541383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the Relationship Between Antibody-Dependent Enhancement and Disease Severity in Secondary Dengue Infection.
    de A Camargo F; Adimy M; Esteva L; Métayer C; Ferreira CP
    Bull Math Biol; 2021 Jun; 83(8):85. PubMed ID: 34142264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B; Boots M
    J Theor Biol; 2006 Sep; 242(2):337-46. PubMed ID: 16631802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antibody-dependent enhancement, cross immunity, and vector population on the dynamics of dengue fever.
    Hu K; Thoens C; Bianco S; Edlund S; Davis M; Douglas J; Kaufman JH
    J Theor Biol; 2013 Feb; 319():62-74. PubMed ID: 23206388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus.
    Ripoll DR; Wallqvist A; Chaudhury S
    Front Cell Infect Microbiol; 2019; 9():200. PubMed ID: 31275864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling original antigenic sin in dengue viral infection.
    Nikin-Beers R; Ciupe SM
    Math Med Biol; 2018 Jun; 35(2):257-272. PubMed ID: 28339786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antibody in enhancing dengue virus infection.
    Nikin-Beers R; Ciupe SM
    Math Biosci; 2015 May; 263():83-92. PubMed ID: 25707916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical models for dengue fever epidemiology: A 10-year systematic review.
    Aguiar M; Anam V; Blyuss KB; Estadilla CDS; Guerrero BV; Knopoff D; Kooi BW; Srivastav AK; Steindorf V; Stollenwerk N
    Phys Life Rev; 2022 Mar; 40():65-92. PubMed ID: 35219611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of demographic and environmental variability on disease outbreak for a dengue model with a seasonally varying vector population.
    Nipa KF; Jang SR; Allen LJS
    Math Biosci; 2021 Jan; 331():108516. PubMed ID: 33253746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan.
    Wang WH; Urbina AN; Wu CC; Lin CY; Thitithanyanont A; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    Int J Infect Dis; 2020 Apr; 93():151-159. PubMed ID: 31982624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal age of vaccination against dengue in Brazil based on serotype-specific forces of infection derived from serological data.
    Maier SB; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Math Med Biol; 2021 Mar; 38(1):1-27. PubMed ID: 32671383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity.
    Izmirly AM; Alturki SO; Alturki SO; Connors J; Haddad EK
    Front Immunol; 2020; 11():1055. PubMed ID: 32655548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-Cell mediated adaptive immunity and antibody-dependent enhancement in secondary dengue infection.
    Sasmal SK; Takeuchi Y; Nakaoka S
    J Theor Biol; 2019 Jun; 470():50-63. PubMed ID: 30878699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.